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Abstract  
 
Data management and data facilitation is the foundation and a critical part for 
scientific investigations, especially with large cohort studies on health care, which 
may have multiple components collected from different institutes or different areas 
due to efficiency, cost, enrollment considerations. In this thesis, I consider how to 
design and to implement data management with multi-center health care research 
data. The research project that I joined focuses mainly on environmental health 
science, and the primary goal is to investigate the impact of nutritional and toxicant 
exposures in environment during fetal and early postnatal life on individual’s health 
outcomes over the life course. More specifically, I will present my work in a newly 
established research project, ECHO (Environmental Influences on Child Health 
Outcomes), on designing the data management plan and program codes for the data 
management and modeling core, facilitating and accomplishing data communication, 
cleaning and unifying data labels and formats, preparing datasets to achieve 
desirable data structures for further statistical analysis, and controlling data quality to 
ensure the overall research quality. 
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Chapter 1. Introduction 
  
1.1 Background and Significance  
Basic and social sciences have independently advanced conceptual frameworks 
grounded in a developmental paradigm as a basis for understanding how early life 
exposures influence health over the life course. However, social and chemical 
exposures are not independent of each other. It is important to investigate not only 
the direct effects but also the interactions of social context and chemical exposures at 
key developmental periods as the health scientists try to understand how these confer 
to long-term susceptibility to obesity and adverse neurodevelopmental outcomes. 
The ‘developmental origins’ hypothesis postulates that nutritional and toxicant 
exposures during fetal and early postnatal life influence developmental plasticity 
through epigenetic mechanisms, altering susceptibility to chronic conditions in later 
life [1]. The Environmental Protection Agency (EPA) incorporated the concept of 
life stage exposures into its risk assessment and regulatory framework [2, 3], 
recognizing that exposures during vulnerable periods may affect health outcomes 
that do not manifest until many years later. In their influential article on critical 
windows of toxicant exposure, Selevan, et al.[4] noted that research on exposures in 
utero is more advanced than that considering adolescence, a biologically vulnerable 
period characterized by hormonal changes and maturation of many organ systems.  
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Perspectives from public health and social sciences underscore the relevance of 
multi-level influences during the perinatal and pubertal periods as well as other key 
developmental stages, including the transition from early to mid-childhood and from 
adolescence to young adulthood.  
There has been a large body of literature working on environmental health, which 
has advanced the concept of the “exposome” that echoes developmental paradigms 
in basic and social sciences. At its essence, the exposome is the environmental 
equivalent of the genome and encompasses all lifetime exposures including 
chemical, lifestyle, dietary and other physical influences. Multiple definitions exist 
[5-8], all highlighting the broad range of exposures that may shape health and 
disease across the life course. Improving detection of internal biomarkers of 
exposure and response is an area of rapid technological development, but 
approximating the entire exposome may be decades away [6, 9]. Integrating data on 
biological responses to social and chemical exposures across multiple developmental 
time periods is essential to develop a more complete picture of the exposome.  
Understanding how biologic responses to exposures may impact obesity, cognition 
and behavior requires, nevertheless, the selection of mediators that reflect change 
across developmental trajectories. Current evidence links social and toxicant 
exposures during discrete developmental windows to risk of obesity and/or poor 
neurocognitive health. Few birth cohorts with repeat toxicant exposures over 
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sufficient length of follow-up also collect nuanced measures of socioeconomic status 
(SES) and parenting. Thus, our ability to understand how interactions of social 
context with chemical exposures may affect neurodevelopment and risk of obesity 
and metabolic squeal during multiple sensitive periods is limited. To address these 
challenges, a multi-center large cohort study has been proposed by leveraging the 
research infrastructures and data from environmental influences on Child Health 
Outcomes (ECHO). This study is a multi-center large cohort study, which includes 
three specific study cohorts: the Fragile Families and Child Wellbeing Study (FF), 
Early Life Exposures in Mexico to Environmental Toxicants study (ELEMENT), 
and Center for Oral Health Research in Appalachia study (COHRA). This 
dissertation work is mainly focusing on data management and data facilitation in this 
multi-center large cohort study. Below, I will introduce specifically more details of 
ECHO data management and each ECHO study cohort. 
1.2 ECHO DMMC and ECHO study cohorts 
ECHO (environmental influences on Child Health Outcomes) is a multi-center 
research investigation proposed to understand how the social and chemical 
environment is associated with the biophysiologic mediating mechanisms and how it 
may affect the obesity-related and cognitive outcomes from fetal life through the 
transition to young adulthood. This study involves four research institutes and 
collected data from three study cohorts with repeated measurements measured 
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longitudinally. The Fragile Families study has 925 participants; the Early Life 
Exposures in Mexico to Environmental Toxicants study has 800 participants; and the 
Center for Oral Health Research in Appalachia study has 1280 participants.  
My work belongs to the data management and modeling core (DMMC) of ECHO. 
My primary goal is to provide high quality data management on these 3005 children 
to further enable scientific discovery, and to organize data ultimately useful in 
informing evidence-based interventions. In the research plan of ECHO, a sub-cohort 
of 200 participants from ELEMENT study and FF study will obtain richly 
characterized intergenerational exposure measures, including exposome and 
epigenome data. Each of the three studies has already collected large amounts of 
high quality, validated data on a broad set of areas. For example, all three studies 
already have measures of obesity, neurodevelopment, social variables, and so on. 
ECHO will collect new data, and further harmonize a variety of data across the three 
study cohorts: FF, ELEMENT, and COHRA.  
The Fragile Families and Child Wellbeing Study (FF) is a landmark, nationally 
representative child development study of the effects of poverty, parenting and other 
social exposures on child health, obesity, cognitive and social development, school 
readiness, and academic achievement. The Early Life Exposures in Mexico to 
Environmental Toxicants (ELEMENT) is an award-winning cohort study, where the 
chemical exposures of ELEMENT participants have been characterized from the 
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prenatal period, and the health outcomes of interest include cognition, behavior, 
sexual maturation and an array of obesity-related outcomes, including metabolomics; 
the Center for Oral Health Research in Appalachia (COHRA) study is collecting a 
unique cohort of mother-infant pairs from northern Appalachia to evaluate the 
factors predisposing to disproportionately high rates of poor oral health.  
I am mainly involved in the ECHO data Management and Modeling Core (DMMC). 
ECHO DMMC plays a central role of liaison in coordinating and giving updates on 
the progress of data collection, data QC, data transfers, and data analysis results, and 
publications among cohorts. Professional data mangers and statisticians handle the 
data analysis part. In this dissertation, I designed a data management plan for ECHO 
DMMC. Since not all the data are available yet and some sub-studies are still 
collecting data, my major focus is on data processing from the ELEMENT study to 
illustrate how the data management and data organization process as proposed work. 
My main responsibilities in this work include data management, data integration, and 
data harmonization, which will handle parts of the existing databases from 
ELEMENT, COHRA and FF studies and new data to be collected to address 
ECHO’s proposed scientific aims. My focus is to design a data management plan 
and provide some strategies to establish the centralized data coordination handling 
data inquiries pertaining to database from two or more cohorts, while individual 
cohort databases are stored in separate study sites. The data management strategies 
we are working on can maximally utilize the existing data management 
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infrastructure to support the ECHO proposed research activities. Specifically, I 
designed both online data require form and feedback form to facilitate data 
communications. I wrote the SAS [10-16] codes to implement data harmonization, 
data quality control (QC), and data transfer. SAS is one of the most popular 
statistical software. In this thesis work, I especially focused on SAS data process, 
SAS PROC IMPORT/EXPORT, SAS PROC SQL and some basic SAS STAT 
procedures. My work contributes to the goal of the part of ECHO DMMC, which is 
to manage all raw lab data including data storage, data QC and data transfer. Since 
the data are collected by different staffs at different research institutes, each institute 
may have multiple sites to enroll patients, each sub-study may include several waves 
of patients with data collected at different times, different ages, and repeated 
measures are collected over the time longitudinally, as one can imagine, one of the 
key functions of our DMMC is the coordination among the existing individual 
cohort data management teams, and integration of meta data and data elements 
needed for the proposed study aims. My work in this dissertation covers all of these 
aims, with a major focus on the multiple sub-cohorts in ELEMENT study. I will 
illustrate the data management process and some data analysis process through a 
research investigation on how prenatal and childhood lead exposure affect 
adolescent’s sexual maturation. 
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1.2.1 The Fragile Families and Child Wellbeing Study (FF) 
The Fragile Families and Child Wellbeing Study (FF) is a landmark, nationally 
representative child development study of the effects of poverty, parenting and other 
social exposures on child health, obesity, cognitive and social development, school 
readiness, and academic achievement. This birth cohort study enrolled 
approximately 4900 children born in large U.S. cities between 1998 and 2000. The 
study includes: (1) interviews with mothers and fathers at birth and again when 
children are 1, 3, 5, 9 and 15 years old; (2) medical records for a subset of mothers 
and children at birth; (3) in-home assessments of children and home environments 
when children are 3, 5, 9 and 15 years old; (4) interviews with children at age 9 and 
15; (5) interviews with teachers when children are 3, 5, and 9 years old; and (6) 
saliva DNA samples from mothers and children when children are age 9 and 15, and 
neuroimaging data from a subset of children at age 15. When the corresponding 
sampling survey weights, the data are representative of all births in all US cities with 
populations of 200,000 or more. Additional weights make the data representative of 
births within each city [17]. Response rates for mothers at baseline, calculated as a 
percentage of eligible births, are 86% at year 1, 3, 5, 9, 15 interviews, and for 
children, calculated as a percentage of eligible respondents at each wave, are 90, 88, 
87, 76, 91% respectively. Response rates for DNA at the year 9 interview are 85% 
for children and 79% for mothers; current age 15 response rates appear slightly 
higher. ECHO plans to collect a new wave of assessments, including blood and urine 
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collection on three of the twenty cities involved in FF (n=925): Detroit, Michigan 
and Oakland and San Jose, California. These three cities were chosen because they 
are in states that afford access to neonatal bloodspots. All participants were recently 
or are currently being interviewed at age 15. By the start of planned data collection 
the oldest would be 20 years old. Birth and early life outcomes will also be collected 
for the children of female FF participants. Of the approximately 430 females in the 
original sample for these three cities we conservatively expect approximately 175 
births throughout the entire project timeline based on the race (10% non-Hisp white, 
47% Black, 45% Hispanic, 3% other), SES (30% <100% the Federal Poverty line 
(FPL), 35% 100-200% FPL, 35% 200%+ FPL) and Age (Mom participants will be 
19-24 during the data collection period).  
1.2.2 The Early Life Exposures in Mexico to Environmental Toxicants 
(ELMENT) 
The Early Life Exposures in Mexico to Environmental Toxicants (ELEMENT) study 
comprises three sequentially-enrolled epidemiologic birth cohort studies in Mexico 
city with the original aim of investigating the influence of lead exposure on various 
outcomes related to fetal and infant development. Pregnant women were recruited at 
maternity clinics of the Mexican institute of Social Security: Cohort 1 was recruited 
from 1994 to 1997; Cohort 2 from 1997-2001; and cohort 3 form 2001 to 2005. In 
2006-2012, study continued follow-up of all 3 cohorts to assess the impact of 
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prenatal lead exposure on neurobehavioral outcomes with specific attention to 
genetic influences of cholesterol metabolism genes. Figure 1 below shows the data 
collection procedure and the timelines. 
 
All three ELEMENT cohorts have the same source of subjects (maternity clinics), 
eligibility criteria and methods when evaluating both fetal and postnatal toxicant 
exposures, covariates and outcomes. ELEMENT participants are generally low to 
middle-class and representative of the general population in Mexico City. All three 
cohorts of ELEMENT have archived biological samples that have been well-
validated for chemical analysis and retrospective exposure assessment, a deliberate 
strategy to ensure the comparability of these subjects and associated data. Our work 
 
Figure 1. Data collection procedure over time and the three waves of study 
cohorts of the ELEMENT study. 
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will further organize the ELEMENT data in a better way and easily allow us to pool 
data across the ELEMENT population to address new scientific investigations. The 
ELEMENT study has been very successful, with its rigorous study design, 
outstanding follow-up rates and multidisciplinary expertise of their team, 
ELEMENT study group has generated over 60 international publications, including 
high impact research on cognitive outcomes related to prenatal exposures to lead 
[18-20] and gene-environment interactions [21]. Evidence from ELEMENT studies 
has informed U.S. lead exposure guidelines including many recent new policy 
statements [22-25]. The current outcomes collected in ELEMENT study include 
cognition and behavior in mid-childhood, obesity and metabolic outcomes including 
metabolomics in peripuberty as well as sexual maturation of physician-observed 
Tanner staging and hormone assays. The careful collection and storage of biological 
samples has allowed the study team to use archived samples to retrospectively assess 
a variety of exposures in the studies of the toxicity of manganese, bisphenol A, 
phthalates, and mercury and so on. Thus, the ongoing funding related to ELEMENT 
has enabled continued follow-up of participants, to assess the impact of EDC 
mixtures and their interaction with diet on growth, maturation and metabolic 
outcomes via epigenetic mechanisms. Potentially, a new wave of assessments, 
including structural brain MRIs at one time point will be collected on 800 
ELEMENT participants currently aged 9-17 years. When combined with the other 
existing assessment collections of ELEMENT, these 800 participants will each have 
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at least two assessments during the transition late adolescence into young adulthood.  
1.2.3 The Center for Oral Health Research in Appalachia (COHRA) 
The Center for Oral Health Research in Appalachia (COHRA) study collected a 
unique cohort of mother-infant pairs from northern Appalachia to evaluate the 
factors predisposing to disproportionately high rates of poor oral health. COHRA 
applies a rigorous multidisciplinary strategy to understand the interrelated factors 
leading to poor oral health in Northern Appalachian children. To achieve this, a 
child- and family-centric study design is employed to combine assessments of 
individuals—their genomes and their personal “environments” (e.g., oral health 
status, oral microbiome, diet, behavior), with family- and community-level variables. 
The ultimate objective of COHRA is to determine targets for interventions that can 
alter the oral health trajectory begun in infancy, thus potentially improve oral health 
throughout life.  
COHRA has recruited two samples from West Virginia and western Pennsylvania: 
COHRA1, a cross-sectional cohort of nuclear families (recruited from 2003 – 2009; 
[26]), and COHRA2, a longitudinal cohort of healthy mother-baby pairs recruited 
during pregnancy and followed until the children are at least age six (recruited from 
2012-present). Trained and calibrated dental hygienists see the COHRA2 women 
and their children at least yearly, beginning before the children are born. In addition, 
the University of Pittsburgh Center for Social and Urban Research (UCSUR) 
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administers an extensive phone questionnaire to all women every six-months. New 
recruitment is ongoing, as are longitudinal follow-up protocols. 
COHRA has produced many high quality peer-reviewed publications, which include 
the first GWAS of any dental disease—dental caries in the primary dentition [27]. 
COHRA data are part of the GLIDE consortium study of periodontal health and BMI 
[28], and also investigated the effect of sibship and caries status on the salivary 
metabolomes of sib pairs with different levels of dental decay [29], caries resistance 
as a function of age [30], demographic, SES, and behavioral factors [31], the nature 
of dental fear and/or anxiety [32, 33], sex differences in caries susceptibility [34, 35]; 
gene-environment interaction between enamel matrix genes and fluoride exposure 
[36], a gene-gender interaction [37], a gene-smoking interaction in periodontal 
disease [39], interaction between depression and rurality for several oral health 
indicators [39], and etc. 
Continued follow-up are planned on 1280 current COHRA participants and 
additional assessments will be collected at 5 and 8 years to coincide with sensitive 
developmental periods for obesity and cognition and socioemotional behavior, as 
well as measures of these outcomes and to provide comparable data on exposures 
(e.g., with the ELEMENT study).  
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1.3 Data Management Plan 
Since this is a multi-center large health care studies cohort, our data management 
and modeling center plays a central role in coordinating and providing updates on 
the progress of data collection, data QC, data transfers, and data analysis results 
among cohorts.  
  
One of ECHO DMMC main role is to handle data management, integration and 
harmonization. FF, ELEMENT, and COHRA studies currently maintain databases 
that contain data elements beyond the scope ECHO-DMMC. Hence, the data 
 
Figure 2. The flow chart of ECHO studies, ECHO data, and their connections 
with our data management and modeling core. 
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managed as part of this ECHO- DMMC includes parts of the existing databases from 
FF, ELEMENT, and COHRA and new data collected to address the proposed 
scientific investigations. The ECHO DMMC will lead centralized coordination to 
handle data inquiries pertaining to data from two or more cohorts, while individual 
cohort databases are stored in separate study sites. In this way, the existing data 
management infrastructure will be maximally utilized to support the newly proposed 
research activities, and not duplicated in the ECHO DMMC. The ECHO DMMC 
will manage all data required to address the specific study aims, including data 
storage, data QC and data transfer of newly collected data, and data harmonization of 
existing data elements. To maximize efficiency, each cohort-specific DMMC will be 
responsible for managing new questionnaire-based data from the existing cohort-
specific participants, which will then be combined by the ECHO DMMC for 
analysis. The ECHO DMMC will manage all raw lab data including data storage, 
data QC and data transfer. Figure 2 present an organizational chart in which one of 
the key functions of the ECHO DMMC includes the coordination among the existing 
individual cohort data management teams, and integration of meta data and data 
elements needed for the proposed study aims.  
Each individual cohort DMMC will include faculty statistician, a database manager 
and an analyst, covering basic data management needs, including integrating new 
data to be collected in this proposal to the cohort- specific databases, and basic data 
analysis of each cohort. These personnel already thoroughly understand the data 
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structure and contents of the individual cohorts and will also have key 
responsibilities related to data harmonization and integration for the ECHO projects. 
They will collaborate with the ECHO DMMC to create and maintain the overall data 
dictionaries and to extract and transfer any requested data used to fulfill analysis 
goals of the current proposal. As needed, each individual cohort DMMC will 
conduct data analysis of cohort- specific data and develop or apply statistical models 
needed to fulfill analytic needs related to this proposal. In terms of coordination, 
each individual cohort DMMT will be responsible to inform the ECHO DMMC of 
any updates and progress on data collection, data validation, data analysis results and 
publications for each project. In addition, the sharing of statistical models and 
methods used in cohort- specific analysis will be communicated with the statisticians 
serving the other cohorts.  
Professional data mangers and statisticians handle the data analysis part. For the part 
of data inquiry and communication, data harmonization and documentation, and data 
quality control defines my training spectrum and thesis. I ensure that dataset is 
adequately prepared with the appropriate variables in SAS format for further data 
analysis, and get the data easily understood by both research investigators 
(clinicians, medical professionals, professors, and researchers) and statisticians 
(those who perform data analysis). The major procedures that I used in SAS to deal 
with data management include SAS data process, SAS PROC IMPORT/EXPORT 
and SAS PROC SQL. I will also perform some basic analysis to ensure data quality 
  
16	  
control and provide fundamental statistics using SAS stat procedures. 
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Chapter 2. Data Communication  
As we have seen from the introduction in Chapter 1, this is a typical large cohort 
study with data collected at multiple locations, during multiple study waves, and at 
multiple longitudinal time points. To facilitate the communication between scientific 
investigators and the data management group, we design data request forms and data 
feedback forms for people who are interest using our existing meta database for 
further scientific investigations. At the same time when our data management group 
is preparing the desired data structure and dataset for further analysis, we need pay 
attention to the security when transferring data, and especially when connecting to 
different database servers at remote locations. After this, we dynamically modify and 
follow-up data communication online request form to allow more convenience and a 
more systematic data management procedure. Furthermore, we need to establish the 
appropriate notice and data documentation, which help explain the data usage right 
and permission. 
2.1 Semi-automatic online data request process 
According to what is potentially related to people’s interest, and after several data 
process procedures handled manually face to face with the study team, I found it 
would be more efficient if we can develop some semi-automatic procedure for data 
request before face to face meetings. This will help both the scientific investigators 
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and the data manager to make things clarified, documented, and in the meanwhile 
save a lot of time from travelling to meetings.  
The welcome page describes what this website is for, and you can find brief 
descriptions of the existing raw data structures and raw data contents. Along with this 
welcome page, I also provide some guidelines for the data file that will be generated 
by our data management group. For example, where are the variable names, how to 
code missing data, where to find the detailed data dictionary, and what the data 
dictionary contains, and some common coding of the demographics variables. 
 
Welcome to our DMMC (Data Management and Modeling Core)! 
 
You can request a dataset by providing the following information. We will 
prepare the dataset accordingly, along with our priority list. It may take a few 
days, but we will send it back to you as soon as the dataset is ready. 
 
Please note some guidelines for data structure as you receive the requested 
dataset: 
  1. The first row contains a variable name. 
  2. Missing data are coded as NA. 
  3. Each data will come with a detailed data dictionary, including what each 
variable means, the units of continuous measurements, the value of each level 
for categorical variables, etc 
  4. Some common coding for demographics variables:  
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     1) Gender: female=0, male=1 
     2) Race: 1=White 2=African American 3=Hispanic 4=Other 
     3) education level: 1=high school or less 2=two year college 3=four year 
college 4=post graduate degree 
 
Then the investigator will complete the online questionnaire regarding the study they 
propose to investigate. Thus, we at the DMMC will know what variables from which 
cohort may potentially be of their study interest. We will merge and recreate new 
dataset for the investigators to use according to their need. Some sample survey 
questions are:  
 
Which of the following databases do you need to use? 
(  ) Fragile Families (DMMC) include about 15 years data 
( ) ELEMENT (DMMC) include about 20 years data which is 
related to chemical element 
( ) COHRA (DMMC) include about 10 years data which is 
related to children's oral health 
(  ) Other database (please specify) 
What is your project title? 
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Main Scientific Objective? 
Principal Investigator: 
Specific Scientific Questions (please enumerate): 
Outcome (dependent variable): 
Predictors (independent variables): 
Potential Confounders: 
 
This semi-auto data request form can be completed online at the DMMC website, 
and the completed form will be automatically sent to a specific data manager’s 
mailbox. Once ECHO DMMC receives the completed data request form, ECHO 
DMMC manager will go over all existing raw data files and locate the appropriate 
study cohort(s) correspondingly, and then organize a new dataset or several datasets 
if needed according to years or other specified data request requirements. This semi-
auto procedure can be done easily and quickly without too much interactions 
between personnel. Following this step, the investigator and the data manager can sit 
down and meet in person or over the phone with the semi-auto prepared dataset(s) of 
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their potential interest in front of them and see if they need to modify, further 
generalize or detailed tailoring of the data. 
2.2 Securely transfer data and privacy protection  
For complex computer world, hackers are more techs savvy and can infiltrate 
networks by exploiting vulnerabilities. Especially in the case when people’s health 
care data are involved, it is very important to ensure data security and privacy 
protection. For ECHO DMMC, we consider the following methods that can help us 
achieve the aim of keep data security and confidential data privacy. First, before 
manipulating data for further structure changes, we make a copy of the raw data and 
safely save raw data with password protections, and even on private computer/server 
isolated from any Internet or other user use. Secondly, when carrying out the 
processing procedure, we always set safe password for connection servers. For 
example, with any remote connection to different locations when searching data, we 
always use SAS secure link/connections with password saved in a separate file 
directory. Another idea is setting encryption competence measure for ECHO DMMC 
data manager.  
2.3 Data follow-up communication   
The semi-auto process has been in use since I developed the online request form on 
their website this summer.  Several studies have been proposed and got the dataset 
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generated by that way. We further developed a series of follow-up communications 
between data manager and scientific investigators to monitor the data creating 
process, data safety issues, and collect feedbacks from both sides on how to improve 
the process.  
2.4 Data use permission and agreement 
As many other study/protocol/grant, a data use permission and data use agreement 
(DUA) is necessary to ensure data safety and data privacy during the transfer of data, 
especially when the data is nonpublic or is otherwise subject to some restrictions on 
its use. Typically, this is a contractual document on the agreements that is required 
under the Privacy Rule and must be entered into before there is any use or disclosure 
of a limited dataset to an outside institution or party. Like in our study, any data 
created by our data management group is a necessary component of the research 
project and it does contain human subject data. So the institutes involved in ECHO 
want to ensure that DUA terms protect confidentiality when necessary, but permit 
appropriate publication and sharing of research results in accordance with University 
policies, applicable laws and regulations, and federal requirements.  Therefore, the 
team established the corresponding data use permission and agreement to help 
restrict the use and disclosure of the data set, and, under these restrictions, our 
DMMC team prepare and unify the format of newly created datasets in the form 
appropriate for the transfer of data. 
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Principal Investigator (PI) creates and submits the data request in the secure intranet 
online system. To avoid any delays in processing, the PI/PI's department should 
ensure that the PI has completed his/her annual Conflict of Interest (COI) disclosure 
using the Faculty/Researcher form. Upon electronic receipt of a new submission, the 
project coordinator will begin initial submission review and will contact the PI or 
their administrative contact if any of the required documentation is missing or 
incomplete. Then data use agreement will be circulated for signatures. When all of 
the required documentation has been received completely, the data request will be 
assigned and forwarded to a data manager at DMMC officer for review and data 
preparation. The data use permission and agreement file may include the 
components similar as follows: 
• Establish the permitted uses and disclosures of the limited data set;  
• Identify who may use or receive the information; 
• Prohibit the recipient from using or further disclosing the information, except 
as permitted by the agreement or as otherwise permitted by law; 
• Require the recipient to use appropriate safeguards to prevent an 
unauthorized use or disclosure not contemplated by the agreement; 
• Require the recipient to report to the covered entity any use or disclosure to 
which it becomes aware; 
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• Require the recipients to ensure that any agents (including any 
subcontractors) to whom it discloses the information will agree to the same 
restrictions as provided in the agreement; and 
• Prohibit the recipient from identifying the information or contacting the 
individuals. 
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Chapter 3. Data Harmonization, Data preparation, and 
Data documentation 
In this chapter, I will present details about the data process procedure that I have 
done every time I receive a data request.  Following by the data request form, I will 
locate what parts of the whole data collection can be used to establish the specific 
scientific investigation according to their main scientific objectives and specific 
scientific questions. They mainly have listed their targeted outcome and potential 
predictors and confounds that they want to include. I will also go through the whole 
study and see if there is anything they may have missed and will add in, just for their 
potential interest. After I located every piece and where they are saved in the raw 
datasets, I will employ SAS DATA process, SAS PROC IMPORT/EXPORT, and 
SAS PROC SQL to perform Data Harmonization and Data preparation. I will also 
use both SAS and Word to prepare the corresponding Data archive files and Data 
documentations. In the following, I will mainly focus on the data management in 
ELEMENT with multiple waves and repeated measurements, as this part of the data 
is ok to present at this moment while all other part of the data are still confidential 
outside the study team. I will specifically illustrate the whole process through a 
specific project, which is mainly proposed to evaluate the effect of the environmental 
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exposures such as prenatal and childhood lead exposure on adolescent's sexual 
maturation. 
3.1 Introduction to the Data Structure of ELEMENT Study 
ELEMENT is comprised of three birth cohorts from Mexico City maternity hospitals 
that have been successfully followed for over two decades. The study cohorts 
(mother-infant pairs) were recruited from three maternity hospitals in Mexico City 
that serve a low- to moderate-income population (Mexican Social Security Institute, 
Manuel Gea Gonzalez Hospital, and National Institute of Perinatology). The initial 
cohort began with the support from the Harvard Superfund Basic Research Program 
and individual R01 grants and was an inter-institutional collaboration among 
Harvard University, the Center for Population Health Research of the national 
Institute of Public Health in Mexico, the American British Cowdray Medical Center 
and the National Institute of Perinatology of Mexico, with approval from each study 
location’s Institutional Review Board (IRB). With the movement of multiple 
ELEMENT investigators from Harvard University to the University of Michigan 
between 2006 and 2008, and from the University of Michigan to the University of 
Toronto, the ELEMENT cohort has evolved into a collaboration among researchers 
at University of Michigan, Harvard, and the University of Toronto with continued 
interaction with all partner agencies in Mexico. At University of Michigan, School 
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of Public Health (UM-SPH) data were extracted or newly collected from the existing 
three birth cohorts. 
The mother-child pairs of study participants were recruited over a series of years: 
Cohort 1, 1994-1997; Cohort 2, 1997-2000; Cohort 3, 2001-2005. Data was 
collected at various times throughout the prenatal period, early- to mid-childhood 
and adolescence in Cohorts 1, 2, and 3, with significant overlap in data collected 
during pregnancy, infancy and early childhood through age five (See Figure 1 on 
Page 9). A fourth cohort began in 2007 under a similar study design. Some of the 
information collected is common between cohorts and some differs slightly, as 
measures have evolved over time for improved accuracy and precision. Table 1 
below is a general compilation of data collected across the children’s life stages for 
all ELEMENT cohorts, so specific variables may not be available in all subjects. 
Since ELEMENT is an ongoing, longitudinal cohort, additional measures may be 
added in future studies. Table 2 reflects data that has been collected from 1994 
through 2014, which provides a rich source of secondary data potentially proposed 
by the investigators. 
All data collection for the ELEMENT studies occurs in Mexico, facilitated via 
collaboration with the Instituto Nacional de Salud Publica (INSP) that has existed 
since the longitudinal cohort was initiated in 1994. Study subjects include mother-
child pairs who were originally recruited for ELEMENT participation before or duri- 
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Table	  1.	  ELEMENT	  Data	  Collected	  Across	  Children’s	  Life	  Stages	  for	  Cohorts	  1,	  2,	  and	  3	  
Child’s	  Lifestage	  
Study	  Data	  Collected	  
Maternal	  Measures	   Child	  Measures	  
Prenatal	   • Socio-­‐economic	  status	  (2	  PL	  
• Urine	  
• Venous	  blood	  (2	  PL	  
• Food	  frequency	  questionnaire	  
(FFQ)	  
• Socio-­‐economic	  status	  
questionnaire	  
	  
	  
Perinatal	   • Socio-­‐economic	  status	  
• Patella	  and	  tibia	  bone	  lead	  
• Venous	  blood	  	  
• Urine	  
• Anthropometry	  
• Birth	  weight	  
• Birth	  length	  
• Umbilical	  cord	  blood	  
• Bayley	  Scales	  of	  Infant	  Development	  
II	  (Spanish)	  
Early	  Childhood	  
(0-­‐5	  years	  old)	  
• Anthropometry	  
• FFQ	  
• Demographic	  information	  
• Socio-­‐economic	  status	  
• Maternal	  IQ	  	  
• Anthropometry	  
• Bayley	  Scales	  of	  Infant	  Development	  
II	  (Spanish)	  
• Mental	  Development	  Index	  
• McCarthy	  Scales	  
• FFQ	  
Mid	   Childhood	  
to	  Adolescence	  
(7-­‐16	  years	  old)	  
• Screening	  questionnaire	  
• Sociodemographic	  questionnaire	  
• FFQ	  
• Lead/Metals	  exposure	  
questionnaire	  
• GPS	  coordinates	  
• HOME	  Inventory	  
• Blood	  
• Hair	  
• Nails	  
• Urine	  
• Anthropometry	  (Height,	  weight,	  
waist,	  chest,	  arm,	  and	  calf	  
circumferences)	  
• Blood	  pressure	  (simplified)	  
• Skinfold	  thickness	  
• Psychometric	  tests	  (BASC-­‐2,	  
CADS,	  BRIEF,	  Structured	  
Interview)	  
• Anthropometry	  (Height,	  weight,	  
waist,	  chest,	  arm,	  and	  calf	  
circumferences)	  
• Blood	  pressure	  
• Skinfold	  thickness	  
• Bioelectrical	  impedance	  
• Stage	  of	  sexual	  maturation	  
• FFQ	  
• Psychometric	  tests	  (CANTAB,	  
WRAVMA,	  BASC,	  CADS,	  BRIEF,	  WASI,	  
Connors’,	  Pre-­‐Pulse	  Inhibition)	  
• Blood	  	  
• Hair	  
• Nails	  
• Urine	  
• DNA	  (saliva)	  
• Accelerometry	  data	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ng pregnancy or shortly after giving birth, depending on the cohort. Current and 
future studies based on this longitudinal cohort re-recruit mother child pairs to 
explore related research study aims and continue to recruit new birth cohorts. 
Primary data is collected in multiple locations in Mexico, depending on the specific 
study requirements; these study locations include La Casita, the American British 
Cowdray Medical Center, and the Instituto Nacional de Perinatologia (INPer). 
Primary data for ELEMENT studies falls into three general categories: (1) data 
collected via filling out the Study Visit Data Collection Form or study questionnaires 
that is written on paper and directly entered into a database by the INSP Data Entry 
Technician or practitioners at one of the clinical study locations, (2) data collected 
from the visit that is directly entered by study practitioners into the computer via 
secure form and (3) biological specimens that require analysis prior to generating 
quantitative data that can be entered into a database. Examples of primary data that 
are recorded on paper during the study visit include: socio-economic status, 
demographic information, and responses to questionnaires. Data that is entered into a 
computer form during the study visit includes anthropometric data. Biological 
specimens may include urine, saliva, hair, nails, serum, and plasma. Multiple health 
outcomes can be assessed from each of these biological specimens and analyses vary 
by study.   
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3.2 Our Plan for Data Harmonization and Data 
Documentation  
 
Figure 3 presents the flow chart of data collection, data entry, data management and 
data analysis in the ELEMENT study. At the current stage, we have transferred all 
Figure 3. The flow chart of data collection, data entry, data management 
and data analysis in ELEMENT study. 
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the raw data in a secure,	   shared	   computer	  drive	   internally	  used	  by	   the	   research	  group	  
members	   with	   authorization.	   The	   original	   folder	   was	   created	   for	   the	   multiple	   founded	  
projects	   related	   to	   the	  ELEMENT	  cohort,	   and	   contains	   the	  most	   comprehensive	  historical	  
data,	  including	  those	  from	  the	  earliest	  cohorts.	  A	  detailed	  description	  of	  all	  the	  cohorts	  can	  
be	  found	  in	  the	  table	  below:	  
Table	  2.	  ELEMENT	  Raw	  Database	  Collected	  over	  2000	  subjects.	  
Cohort	  1	  (1994-­‐1997)	   Cohort	  2	  (1997-­‐2000)	   Cohort	  3	  (2001-­‐2005)	  
C1	  –	  Cohort	  1	  
§ Followed	  48	  months	  
§ Birth	  cohort	  
§ Mother	  followed	  12	  months	  
for	  breast	  feeding	  study	  
§ Proyecto	  +	  filio	  
PL	  –	  Plasma	  
§ Followed	  60	  months	  
§ Pregnancy	  cohort	  	  
	  
BI	  –	  Biomarker	  
§ Followed	  60	  months	  
§ Birth	  cohort	  
§ foliocc	  
SF	  –	  Super	  Fund	  
§ Followed	  60	  months	  
§ Pregnancy	  cohort	  
	  
	  
	   	  
 
Cholesterol	  (2006~2007)	  
§ Subjects	  came	  from	  C1,	  PL,	  BI	  and	  SF	  
	  
P20	  (2010,	  n	  =	  250)	  
§ Subjects	  were	  subset	  of	  Cholesterol	  study	  (i.e.,	  PL+SF+BI)	  
	  
P01	  (2015)	  
§ New	  data	  collecting…	  
 
For security considerations, the raw data can only be accessed by the specific data 
manager assigned through the study team. All data are saved under a master Excel 
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sheet, where each separate Excel sheet is used to save data related to recruitment, 
surveys, and ultrasound data. Those files related to documentations, explanations, 
and presentations are also saved here and can be accessed in the same way. At 
DMMC, we have cleaned the data, unified the coding of common variables, created 
understandable labels for each variable in the dataset, converted them to SAS data 
files when needed, re-organized and restored the excel data files in the following 
way according to functional variables. Figure 4 shows the newly reconstructed data 
structure.  
 
 
Figure 4. The new structure of our database with four modules 
and available sets of functional variables stored in each module 
for the ELEMENT study. 
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This new data structure has four modules: Historical (1994-2005), Cholesterol 
(2007), P20 (2010), and P01 (2015). Within each module, Figure 4 listed its sub-
databases with specific functional meanings and documented the timing of 
measurements within that module. This new data structure is easier for data 
managers to locate the necessary variables of any newly proposed secondary data 
analysis or scientific investigation. In more details, my work in the group 
involved the following components: 
• Create and maintain a common database for human studies related to the 
ELEMENT study cohorts 
• Develop standard code for common outcomes, unify coding for common 
variables, create labels and unified format to harmonize the datasets 
• Develop SAS code for data cleaning, data merging, and data 
reorganizations 
• Develop standard code for data validation for data quality control 
• Develop SAS codes to provide data statistics, and to perform simple data 
analysis.  
Below I will illustrate my work through a concrete example, where the goal is to 
investigate how the prenatal and childhood environmental exposures such as lead 
exposure affect adolescent's sexual maturation. 
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3.3 A Case Study for Data Preparation Process: To investigate 
how the environmental exposures such as prenatal and 
childhood lead exposure affect adolescent's sexual 
maturation. 
3.3.1 Study goal 
ELEMENT uses self-reported and physician-assessed Tanner Staging for genital 
(boys), breast (girls), and pubic hair (both) development [40, 41] starting at 
approximately 8 years of age. FF collects Tanner Staging via self-report from the 
primary caregiver at age 9 and 15 years. COHRA children will have reached 8 years 
of age by the end of the proposed follow-up period; thus, at this point in time, the 
study plan to collect proxy-assisted Tanner Stage from the primary caregiver. By 
leveraging all these data from three studies in an appropriate way, one can evaluate 
how the prenatal and childhood environmental exposures such as lead exposure 
affect adolescent's sexual maturation. Obviously, since the data are collected by 
different study groups initially, and they have different formats and different 
codings. One major job of DMMC will include some time-consuming but necessary 
across cohort data harmonization and documentations. Since other data are 
confidential, we will only present the work and results done with ELEMENT data. 
Even within ELEMENT, as we described earlier, the data were collected during 
different waves on different cohorts, and at different locations, data harmonization is 
still a big challenge for further meta-analysis. The primary objective of data 
  
35	  
harmonization in ELEMENT is to understand inter-cohort commonalities and 
heterogeneities, and to  develop data harmonization and analytical approaches to 
address key data discrepancy issues. 
3.3.2 Fill in online request form 
By filling out the online data request form, the following major information has been 
provided by the study investigator, Dr. Peter Song, for the scientific investigation on 
how adolescent's sexual maturation can be potentially affected by the prenatal and 
childhood environmental exposures such as heavy metal exposures, lead exposures.  
Project title: ELEMENT Sexual Maturation Study 
Main Scientific Objective: How prenatal and childhood lead exposure affect 
adolescent's sexual maturation 
Principal Investigator: Peter Song 
Specific Scientific Questions: 
1. Is there an association between Mom's prenatal lead exposure with kid's 
sexual maturation? 
2. Is there a vulnerable window (like which trimester is more important)? 
3. Is there a relationship between children's childhood lead exposure with 
kid's sexual maturation? 
Outcome (dependent variable): sexual maturation outcomes (self reported, or 
physician diagnosed) 
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Predictors (independent variables): all kinds of Mom's lead exposures, kid's lead 
exposures, demographics. 
Potential Confounders: kid's longitudinal measurements of health outcomes, age, 
gender, race... 
3.3.3 Data allocation in the database 
After I received the data request form, I went through all details filled in the form, 
and notice the main piont that this newly proposed secondary analysis is to 
investigate how prenatal and childhood lead exposure affects adolescent’s sexual 
maturation. Then I dig into the massive database and try to locate the information 
that is related to express the levels each kid’s sexual maturation. In ELEMENT, the 
sexual maturation inforamtion is collected for each kid through both self report 
questionaires, and physician’s examination and scoring. For physician scoring, they 
have a rigorous 4-page form to fill in, and all information is recorded in the data base 
from each question in that form. Specifically, the following variables are of our 
interest for the physician observed sexual maturation. 
TN15_1: Physician observed pubic hair staging 
TN15_2: Physician observed breast development (female only) 
TN15_3: Physician observed genital development (male only) 
TN15_4A: Physician observed testicle volume (male only), right 
TN15_4B: Physician observed testicle volume (Male only), left 
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For girls, the self report questionaire is as in Figure 5: 
The related variables that I locate in the database include the following:  
F5:	  Have	  you	  started	  having	  periods?	  
F6:	  If	  yes,	  at	  what	  age?	  
F6B_AA:	  First	  period	  (Year)	  
F6B_MM:	  First	  period	  (month)	  
F6C_AA:	  Last	  period	  (year)	  
F6C_DD:	  Last	  period	  (day)	  
F6C_MM:	  Last	  period	  (month)	  
F9:	  Please	   choose	   the	  drawing	   closest	   to	   your	   stage	  of	  breast	  development	  by	  
marking	  your	  answer	  with	  a	  cross	  
 
Figure 5. Self-reported questionaire for girls’ sexual maturation in ELEMENT. 
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F10:	   Another	   changes	   is	   the	   growth	   of	   pubic	   hair.	   	   Please	   choose	   the	   drawing	  
closest	  to	  your	  stage	  of	  hair	  development	  by	  marking	  your	  answer	  with	  a	  cross	  
 
The self-reported questionaire for boys is as in Figure 6, 
 
and the related variables that I locate in the database include the following:  
M7:	  Your	  stage	  of	  penis	  and	  scrotum	  development	  
M8:	  Your	  stage	  of	  pubic	  hair	  development	  
 
Figure 6. Self-reported questionaire for boys’ sexual maturation in ELEMENT. 
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Similar data information related to sexual maturation is saved within P20(2010) 
module separately in three different datasets (P20_Adolescent_Maturation_F.csv, 
P20_Adolescent_Maturation_M.csv, P20_Adolescent_Maturation_P.csv), as well as 
within P01(2015) module in one big dataset (P01_Adolescent_Maturation.csv with 
totally different variable names), and within Cholesterol(2007) module in one dataset 
but with simpler questionaire designed at that time and thus less data information 
collected (Cholesterol_Adolescent_Maturation.csv with only similar questions to F9, 
F10, M7, M8 listed above).  
Obviously, the main predictors for this project will need to include all longitudianl 
measurements of both Mom’s prenatal lead exposures and kid’s lead exposures in 
their early lives. These exposure measurements are all saved in the Historical(1994-
2005) module. Specifically, we located two databases related to lead exposure 
records and extracted them into two data files: “Historical_Child_Blood_Lead.csv” 
and “Historical_Mom_Blood_Lead.csv”, with much simpler data structure. One 
contains child blood lead level from month 1 to 60, and the other contains mom 
blood bead level from trimester 1 to time when child is 12 month of age. Besides, we 
also need to include other covariates in the database such as demographics( age, 
race, gender, weight, height, and BMI), and some other potential confounders, for 
instance, kid’s longitudinal measurements of health outcomes, Mom’s age of at 
delivery, smoking status of Mother, etc. Such information can be found in all four 
data modules: Historical (1994-2005), Cholesterol (2007), P20 (2010), and P01 
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(2015). The specific 4 datasets related to demographics and other health outcome 
records of either kid or mom are: “Cholesterl_Adolescent_Anthro.csv”, 
“Historical_Mom_General_Info.csv”, “P20_Adlescen_Anthro.csv” and 
“P01_Adlescen_Anthro.csv”. 
 
3.3.4 Data harmonization and documentation 
As we described in the previous session, the data saved in different modules may 
have different formats or different variable names, since they were collected during 
different time periods of the ELEMENT studies. Over the time as the design of the 
study gets improved, some new information is collected while it was not at an earlier 
stage or wave of cohorts. To achieve data harmonization, we (1) created overall data 
dictionaries of the existing data to transfer knowledge of the entire data availability 
to all investigators; (2) tried to understand commonalities and heterogeneities across 
different longitudinal study cohorts of ELEMENT, with respect to study design, data 
collection procedure, study population, measurements and cohesiveness of data 
sources across different cohort studies, and (3) identify any missing data, and 
examine the consistency, availability and variability of variables measured across 
different study cohorts, and develop data harmonization approaches to addressing 
key data discrepancy issues. After all these cleaning and harmonization work, I read 
in the corresponding files about the 11 datasets mentioned in Section 3.3.3 in SAS, 
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with unified data format, data structure, variable names, variable labels, and etc. 
According to the submitted data request, I selected 88 related variables to keep in the 
newly created datasets including kid’s sexual maturation outcomes, Mom’s lead 
exposures, kid’s lead exposures, demographics of both mom and kid, and other 
potential confounders. Then I sort each dataset by ID and type of cohort. With this 
sorting, finally, I managed to merge those datasets according to ID and cohort type 
in one data file to deliver. The SAS code for data cleaning, data harmonization and 
data merging can be found in the appendix. Below is the output from SAS about the 
contents of our final data file.  
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Chapter 4. Descriptive Statistics and Data Quality Control 
4.1 Basic Statistical Tools in SAS for Descriptive Statistics 
and Detecting Potential Outliers 
Descriptive statistics provide simple summaries about the study cohort and the 
various measures collected in the dataset, which are typically employed by data 
manager to quickly take a snapshot of the data in a study, describe the basic features 
of the dataset prepared, and help detect some potential data errors, such as entry 
typos, missing values, outliers by mistakes. Together with simple graphics analysis, 
they form the basis of virtually every quantitative analysis of data. [42, 43] 
For each univariate variable, descriptive analysis involves describing the distribution 
of a single variable (including the mean, median, range, variance and standard 
deviation). Characteristics of a variable's distribution may also be depicted in 
graphical or tabular format, including histograms, box-plot and stem-and-leaf 
display. With bivariate or multivariate analysis, descriptive statistics may be used to 
describe the relationship between pairs of variables. In this case, some descriptive 
statistics that can be used are: scatterplots, quantitative measures of dependence, 
spaghetti plot for longitudinal trajectory, and etc. Bivariate analysis can also be used 
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to describe the relationship between the dependent variable and the predictors. The 
slope in regression analysis, for example, can reflect the relationship between 
variables. Descriptive analysis can also help examine the skewness of data 
distribution and help justify whether certain transformation such as log 
transformation is necessary for each variable. Use of log transformation makes data 
distribution more symmetrical and look more similar to the normal distribution, 
making them easier to interpret intuitively. More complicated statistical methods can 
be found in the literature to validate the data integration procedure when performing 
formal statistical inferences for merged data. [44-47] 
 
4.2 Example of Data Quality Control when Preparing Data 
for investigating how the environmental exposures such as 
prenatal and childhood lead exposure affect adolescent's 
sexual maturation. 
We first examined every univariate to detect some potential problems, such as 
missing values, potential outliers due to entry mistakes, whether range, median 
makes sense, etc. Then we compared sub-cohorts between different sexual 
maturation level groups. The following tables summarize the maternal characteristics 
and children’s characteristics stratified by self-reported sexual maturation stages and 
physician judged sexual maturation levels.  
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Table 3: Descriptive Statistics of maternal characteristics and children’s 
characteristics stratified by girl’s self-reported stage of breast development 
Characteristics Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 
           Maternal 
Age (median, IQR) 26 (8) 26 (5) 27 (9) 23.5 (6) 24 (5) 
Pre-pregnancy BMI (median, 
IQR) 
26.19 (8.41) 28.79 (4.95) 22.33 (1.97) 25.97 (3.22) 24.56 (.84) 
Total months of 
breastfeeding (median, IQR) 
8 (9) 6 (9) 7 (9) 10 (11.5) 7 (15) 
History of smoking      
     Yes 56 (47.86%) 56 (45.16%) 47 (45.19%) 20 (33.9%) 18 (47.37%) 
     No 61 (52.14%) 68 (54.84) 57 (54.81%) 39 (66.1%) 20 (52.63%) 
Smoking during pregnancy      
     Yes 4 (3.42%) 5 (4%) 8 (7.55%) 3 (5%) 2 (5.26%) 
     No 113 (96.58%) 120 (96%) 98 (92.45%) 57 (95%) 36 (94.74%) 
           Child 
Birth weight (median, IQR) 3 (0) 3 (0) 3 (0) 3 (0) 3 (0) 
Birth length (median, IQR) 50 (2) 50 (3) 50 (2) 50 (4) 48.5 (3) 
Head circumference 
(median, IQR) 
34 (2) 34 (2) 34 (2) 34 (2) 33 (2) 
Blood pressure (diastolic) 
(median, IQR) 
63 (10) 68 (9) 71 (5) 68 (18) 68 (0) 
Blood pressure (systolic) 
(median, IQR) 
99 (15) 106 (19) 109 (12) 107 (29) 99 (0) 
BMI (median, IQR) 16.99 (3.63) 18.98 (4.74) 21.41 (4.71) 22.7 (4.45) 21.60 (4.15) 
 
Stage 1: The nipple is raised a little. The rest of the breast is still flat. 
Stage 2: The breast is a little larger and the nipple is raised a little more. The darker-colored area around the nipple 
(areola) is a little bit bigger than is State 1. Sometimes you can feel a small lump inside the nipples.  
Stage 3: The darker-colored area around the nipple (areola) and the breast are much larger than in Stage 2 and 
form a mound. The areola does not stick cut away from the breast. 
Stage 4: The nipple and the areola stick out away from the skin and the rest of the breast. 
Stage 5: The nipple sticks out away from the skin and the rest of the breast. The areola is at the same level than the 
rest of the breast 
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Table 4: Descriptive Statistics of maternal characteristics and children’s 
characteristics stratified by girl’s self-reported stage of pubic hair development  
 
Characteristics Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 
           Maternal 
Age (median, IQR) 26 (7) 26 (5) 25 (7) 22 (7) 22 (2) 
Pre-pregnancy BMI 
(median, IQR) 
30.18 (9.49) 24.26 (0) 25.21 (2) 25.30 (.02) 24.56 (0) 
Total months of 
breastfeeding (median, 
IQR) 
7 (9) 7 (9) 6 (9) 7 (10) 5 (10) 
History of smoking      
     Yes 83 (47.98%) 42 (42.42%) 39 (37.5%) 29 (48.33%) 4 (66.67%) 
     No 90 (52.02%) 57 (57.28%) 65 (62.5%) 31 (51.67%) 2 (33.33%) 
Smoking during 
pregnancy      
     Yes 10 (5.78%) 1 (1.04%) 4 (3.7%) 7 (11.11%) 0 (0%) 
     No 163 (94.22%) 95 (98.96%) 104 (96.3%) 56 (88.89%) 6 (100%) 
          Child 
Birth weight (median, 
IQR) 
3 (0) 3 (0) 3 (0) 3 (0) 3 (0) 
Birth length (median, IQR) 50 (2) 49.5 (3) 50 (3) 50 (3) 48 (3) 
Head circumference 
(median, IQR) 
34 (2) 34 (2) 34 (2) 34 (1) 33 (3) 
Blood pressure (diastolic) 
(median, IQR) 
65 (9) 69 (9) 71 (4) 71 (1) n/a 
Blood pressure (systolic) 
(median, IQR) 
100 (18) 99 (18) 110 (16) 111 (3) n/a 
BMI (median, IQR) 17.81 (4.28) 19.30 (6.17) 21.4 (4.36) 21.82 (4.01) 21.39 (5.07) 
 
Stage 1: There is no pubic hair. 
Stage 2: There is a little, long, lightly colored hair. This hair may be straight or a little curly. 
Stage 3: The hair is a little darker, coarse, and more curled. It has spread out and covers almost all the pubic area.  
Stage 4: The hair is now as dark, curly, and coarse as that of a grown woman. The hair covers all the pubic area 
but does not spread out to the thighs. 
Stage 5: The hair is like that of a grown woman (dark, curly, and coarse). The hair forms a triangle covering all the 
pubic area, and has spread out to the inner thighs. 
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Table 5: Descriptive Statistics of maternal characteristics and children’s 
characteristics stratified by boy’s self-reported stage of penis and scrotum 
development  
 
Characteristics Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 
           Maternal 
Age (median, IQR) 25 (7) 23 (6) 26 (7) 26 (7) 24 (13) 
Pre-pregnancy BMI 
(median, IQR) 
21.71 (7.14) 23.95 (2.69) 33.26 (7.82) 26.94 (6.81) 23.80 (13.48) 
Total months of 
breastfeeding (median, 
IQR) 
6 (6) 7 (9) 6 (8) 7 (8) 11 (9) 
History of smoking      
     Yes 26 (45.61%) 72 (44.44%) 43 (35.83%) 46 (50%) 6 (35.29%) 
     No 31 (54.39%) 90 (55.56%) 77 (64.17%) 46 (50%) 11 (64.71%) 
Smoking during 
pregnancy      
     Yes n/a 7 (4.22%) 43 (35.83%) 3 (3.13%) n/a 
     No 57 (100%) 159 (95.78%) 77 (64.17%) 93 (96.88%) 17 (100%) 
            Child 
Birth weight (median, 
IQR) 
3 (0) 3 (1) 3 (1) 3 (1) 3 (0) 
Birth length (median, IQR) 50 (3) 50 (3) 50 (3) 51 (2) 50 (2) 
Head circumference 
(median, IQR) 
34 (1) 35 (1) 34 (2) 35 (2) 33 (2.5) 
Blood pressure (diastolic) 
(median, IQR) 
71 (13) 62 (9) 68.5 (9) 70 (4) 70 (9) 
Blood pressure (systolic) 
(median, IQR) 
99 (18) 102 (16) 107 (12.5) 108.5 (11) 111 (11) 
BMI (median, IQR) 16.36 (5.27) 18.39 (4.92) 20.71 (6.17) 17.97 (6.94) 19.81 (4.86) 
 
Stage 1: The scrotum and penis are the same size as when you were younger. 
Stage 2: The scrotum has lowered a bit and the penis is a little larger. 
Stage 3: The penis is much longer and the scrotum much larger. 
Stage 4: The penis is longer and wider. The scrotum is darker and larger than before. 
Stage 5: The penis and scrotum are the size and shape of an adult. 
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Table 6: Descriptive Statistics of maternal characteristics and children’s 
characteristics stratified by boy’s self-reported stage of pubic hair development 
 
Characteristics Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 
           Maternal 
Age (median, IQR) 25 (7) 26 (8) 26 (7) 25.5 (4) 26 (8) 
Pre-pregnancy BMI 
(median, IQR) 
25.05 (5.22) 22.47 (3) 23.8 (2.96) 26.06 (9.02) n/a 
Total months of 
breastfeeding (median, 
IQR) 
7 (8) 7 (8) 7 (11) 6 (9) 5.5 (5) 
History of smoking      
     Yes 90 (41.86%) 42 (47.19%) 27 (43.55%) 26 (40.63%) 8 (44.44%) 
     No 125 (58.14%) 47 (52.81%) 35 (56.45%) 38 (59.38%) 10 (55.56%) 
Smoking during 
pregnancy      
     Yes 2 (.93%) 9 (9.47%) 1 (1.49%) 2 (3.03%) n/a 
     No 213 (99.07%) 86 (90.53%) 66 (98.51%) 64 (96.97%) 18 (100%) 
            Child 
Birth weight (median, 
IQR) 
3 (1) 3 (0) 3 (1) 3 (0) 3 (0) 
Birth length (median, 
IQR) 
50 (3) 50 (3) 51 (2) 50 (3) 51 (2) 
Head circumference 
(median, IQR) 
34 (2) 34.5 (1) 34 (2) 35 (2) 35 (2) 
Blood pressure 
(diastolic) (median, IQR) 
63 (9) 70 (7) 70 (1) 71 (0) 70 (0) 
Blood pressure (systolic) 
(median, IQR) 
100 (16) 111 (7) 110 (3) 109 (3) 119 (0) 
BMI (median, IQR) 18.24 (4.93) 19.9 (6.1) 21.48 (6.92) 20.77 (7.96) 22.45 (4) 
 
Stage 1: There is no pubic hair. 
Stage 2: There is a little, long, lightly colored hair. This hair may be straight or a little curly. 
Stage 3: The hair is a little darker, coarse, and more curled. It has spread out and covers almost all the pubic area.  
Stage 4: The hair is now as dark, curly, and coarse as that of a grown woman. The hair covers all the pubic area 
but does not spread out to the thighs. 
Stage 5: The hair is like that of a grown woman (dark, curly, and coarse). The hair forms a triangle covering all the 
pubic area, and has spread out to the inner thighs. 
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No obvious outlier has been detected from all sub-group descriptive analysis. 
However, we noticed that maternal BMI is missing for stage 5 group from Table 6, 
while all other variables still have values falling into reasonable range. Need to look 
at the data and see what is going on and whether it is a real missing value.  
Notice we have repeated measurements of child blood lead exposure and mom’s 
blood lead exposure. To capture the change over time, we plotted the boxplot 
trajectory of these two variables across different time in months (Figures 5 and 6).
 
 
Figure 7. Boxplot of Child Blood Lead Over Time, with child’s birth 
as the reference time. 
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Both variables fluctuated over time, which indicated that both mom’s prenatal lead 
exposure and children’s early childhood lead exposure in our study vary as time goes 
on. This could be due to seasonal effect or food, diet, and nutrition effect. Over time, 
the variation of the measurement does not change much. To see how the lead 
exposure is related to kid’s sexual maturation, we further examined the spaghetti  
plots of lead exposure over time stratified by sexual maturation stages (Figures 7 and 
8). As one can see from the figures, across different sexual maturation groups, the 
 
Figure 8. Boxplot of Mom Blood Lead Over Time, with child’s birth as 
the reference time. 
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mother’s blood lead exposure level do differ from one another, so as the child blood 
lead levels, which is relative higher for less sexually matured kids. 
 
 
  
  
 
Figure 9. Spaghetti plot of mom blood lead exposure trajectory over time, 
stratified by different measurements of sexual maturation stages. 
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Figure 10. Spaghetti plot of child blood lead exposure trajectory over time, stratified 
by different measurements of sexual maturation stages. 
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Chapter 5. Summary  
Data management and data facilitation is the foundation and a critical part for 
scientific investigations, especially with large cohort studies on health care, which 
may have multiple components collected from different institutes or different areas 
due to efficiency, cost, enrollment considerations. In this thesis, we have presented 
how we designed and implemented data management with a multi-center health care 
research project, ECHO (Environmental Influences on Child Health Outcomes). This 
research project is mainly focusing on environmental health sciences, and the 
primary goal is to investigate the impact of nutritional and toxicant exposures in 
environment during fetal and early postnatal life on individual’s health outcomes 
over the life course. More specifically, I illustrated my work through an example 
project in ELEMENT study for investigating how the prenatal and childhood 
environmental exposures such as lead exposure affect adolescent's sexual 
maturation. I have presented my work on designing the data management plan and 
program codes for the data management and modeling core, facilitating and 
accomplishing data communication, cleaning and unifying data labels and formats, 
preparing datasets to achieve desirable data structures for further statistical analysis, 
and controlling data quality to ensure the overall research quality. 
 
  
54	  
The study cohorts we considered also have another challenge, i.e. they all include 
repeated measures of social and/or chemical exposure through sensitive 
developmental periods. Approaches to disentangle whether there is variation in 
susceptibility due to timing of exposure are thus needed. In addition to using 
regression models as we presented where exposures measured during a given time 
period are fitted in separate models (one model for each time period of exposure), 
some novel approaches can be applied to consider the entire pattern of exposure 
through the life course as a predictor of the outcome [48, 49]. These methods have 
been used to identify windows of vulnerability to environmental toxicants [49], and 
have been extended to quantify the joint (interactive) effects of two factors (e.g., 
considering chemical exposures and social factors together). It is definitely of great 
future research interest, but is beyond the scope of this thesis. 
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SAS code Appendix: 
/**************************************** PART I read the seven csv files AND MERGE 
**********************************/ 
/*DATA 1.1*/ 
DATA DATA1_1; 
        INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis 
Data\Cholesterol(2007)\Cholesterol_Adolescent_Anthro.csv" DSD FIRSTOBS=2; 
        INPUT FAKEID PROYECTO $ ETAPACC $ SEX_CH WEIGHT_CH HEIGHT_CH AGE X_AGEMONS 
X_CBMI X_ZBFA; 
RUN; 
 
PROC PRINT DATA=DATA1_1; 
RUN; 
 
/*DATA 1.2*/ 
DATA DATA1_2; 
        INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis 
Data\Cholesterol(2007)\Cholesterol_Adolescent_Maturation.csv" DSD FIRSTOBS=2; 
        INPUT FAKEID PROYECTO $ ETAPACC $ F9 F10 M7 M8; 
RUN; 
 
PROC PRINT DATA=DATA1_2; 
RUN; 
 
/*DATA 2.1*/ 
DATA DATA2_1; 
        INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis 
Data\Historical(1994-2005)\Historical_Child_Blood_Lead.csv" DLM='2C0D'X DSD MISSOVER 
LRECL=10000 FIRSTOBS=2; 
        INPUT FAKEID PROYECTO $ PB_C_1 PB_C_3 PB_C_6 PB_C_12 PB_C_18 PB_C_24 PB_C_30 
PB_C_36 PB_C_42 PB_C_48 PB_C_60; 
RUN; 
 
PROC PRINT DATA=DATA2_1; 
RUN; 
 
/*DATA 2.2*/ 
DATA DATA2_2; 
        INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis 
Data\Historical(1994-2005)\Historical_Mom_Blood_Lead.csv" DLM='2C0D'X DSD MISSOVER 
LRECL=10000 FIRSTOBS=2; 
        INPUT FAKEID PROYECTO $ PB_M_11 PB_M_12 PB_M_13 PB_CORD PB_M_20 PB_M_21 
PB_M_23 PB_M_24 PB_M_27 PB_M_212 ; 
RUN; 
 
PROC PRINT DATA=DATA2_2; 
RUN; 
 
/*DATA 2.3*/ 
DATA DATA2_3; 
        INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis 
Data\Historical(1994-2005)\Historical_Mom_General_Info.csv" DLM='2C0D'X DSD MISSOVER 
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LRECL=10000 FIRSTOBS=2; 
        INPUT FAKEID PROYECTO $ AGE_M BIRTHDATE_M $ MARITAL_STATUS WRITE_READ 
SCHOOL_T1 SCHOOLP_T DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC 
DELIVERY_GESTAGE DELIVERY_MULTIPLE  
        DELIVERY_TYPE DELIVERY_SEX DELIVERY_APGAR1MIN DELIVERY_APGAR5MIN 
DELIVERY_PBCORD ROTULA_QUALITYCHECK TIBIA_QUALITYCHECK HRP_PARITY SMHX SMNOW_1MOPP 
CIGSDAY_1MOPP SMPREG CIGSDAYPREG PREPREGNANCYBMI  
        MONTHS_SINCE_QUIT_SMK CALCIUM_TRT BF_TOTAL_1STRECALL FECHANAC $; 
RUN; 
 
PROC PRINT DATA=DATA2_3; 
RUN; 
 
/*DATA 4.1*/ 
DATA DATA4_1; 
        INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis 
Data\P20(2010)\P20_Adolescent_Anthro.csv" DLM='2C0D'X DSD MISSOVER LRECL=10000 
FIRSTOBS=2; 
        INPUT FAKEID PROYECTO $ SEXO_H CD_AGE WEIGHT HEIGHT WAIST TRI_SKIN SUP_SKIN 
SUB_SKIN PR_DIAS PR_SIS X_AGEMONS X_CBMI X_ZBFA; 
RUN; 
 
PROC PRINT DATA=DATA4_1; 
RUN; 
 
 
/*DATA 4.2*/ 
DATA DATA4_2; 
        INFILE "C:\Users\Wei Wang\Google Drive\Wei\thesis\Thesis 
Data\P20(2010)\P20_Adolescent_Maturation.csv" DLM='2C0D'X DSD MISSOVER LRECL=10000 
FIRSTOBS=2; 
        INPUT FAKEID PROYECTO $ SEXO_H F5 F6 F6B_AA F6B_MM F6C_AA F6C_DD F6C_MM F9 
F10 M7 M8 TN13 TN14 TN15_1 TN15_2 TN15_3 TN15_4A TN15_4B; 
RUN; 
 
PROC PRINT DATA=DATA4_2; 
RUN; 
 
/*SORT AND MERGE THE DATA1*/ 
PROC SORT DATA=DATA1_1 OUT=DATA11; 
        BY FAKEID PROYECTO; 
RUN;  
PROC SORT DATA=DATA1_2 OUT=DATA12; 
        BY FAKEID PROYECTO; 
RUN; 
 
DATA DATA1; 
        MERGE DATA11 DATA12; 
        BY FAKEID PROYECTO; 
RUN; 
 
PROC PRINT DATA=DATA1; 
RUN; 
 
/*SORT AND MERGE THE DATA2*/ 
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PROC SORT DATA=DATA2_1 OUT=DATA21; 
        BY FAKEID PROYECTO; 
RUN; 
PROC SORT DATA=DATA2_2 OUT=DATA22; 
        BY FAKEID PROYECTO; 
RUN; 
PROC SORT DATA=DATA2_3 OUT=DATA23; 
        BY FAKEID PROYECTO; 
RUN; 
 
DATA DATA2; 
        MERGE DATA21 DATA22 DATA23; 
        BY FAKEID PROYECTO; 
RUN; 
 
PROC PRINT DATA=DATA2; 
RUN; 
 
/*SORT AND MERGE THE DATA4*/ 
PROC SORT DATA=DATA4_1 OUT=DATA41; 
        BY FAKEID PROYECTO; 
RUN; 
PROC SORT DATA=DATA4_2 OUT=DATA42; 
        BY FAKEID PROYECTO; 
RUN; 
 
DATA DATA4; 
        MERGE DATA41 DATA42; 
        BY FAKEID PROYECTO; 
RUN; 
 
PROC PRINT DATA=DATA4; 
RUN; 
 
/*SORT AND MERGE THE DATA*/ 
PROC SORT DATA=DATA1 OUT=DATANEW1; 
        BY FAKEID PROYECTO; 
RUN; 
PROC SORT DATA=DATA2 OUT=DATANEW2; 
        BY FAKEID PROYECTO; 
RUN; 
PROC SORT DATA=DATA4 OUT=DATANEW4; 
        BY FAKEID PROYECTO; 
RUN; 
 
DATA DATA; 
        MERGE DATANEW1 DATANEW2 DATANEW4; 
        BY FAKEID PROYECTO; 
RUN; 
 
PROC PRINT DATA=DATA; 
RUN; 
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/************************************************************ PART II TIME PLOT 
*************************************************/ 
/*DESCRIPTION OF DATA*/ 
PROC CONTENTS DATA=DATA; 
RUN; 
 
/* CATEGORY OF RESPONSE*/ 
PROC FREQ DATA=DATA; 
TABLES F9 F10 M7 M8; 
RUN; 
 
/*CHILD BLOOD LEAD*/ 
DATA NEWDATA1; 
        SET DATA; 
        KEEP FAKEID SEX_CH F9 F10 M7 M8 PB_C_1 PB_C_3 PB_C_6 PB_C_12 PB_C_18 PB_C_24 
PB_C_30 PB_C_36 PB_C_42 PB_C_48 PB_C_60 ; 
RUN; 
 
DATA NEWDATAC2; 
        SET NEWDATA1; 
        IF F9=1 THEN GROUP1="F9_1"; 
        IF F9=2 THEN GROUP1="F9_2"; 
        IF F9=3 THEN GROUP1="F9_3"; 
        IF F9=4 THEN GROUP1="F9_4"; 
        IF F9=5 THEN GROUP1="F9_5"; 
        IF F10=1 THEN GROUP2="F10_1"; 
        IF F10=2 THEN GROUP2="F10_2"; 
        IF F10=3 THEN GROUP2="F10_3"; 
        IF F10=4 THEN GROUP2="F10_4"; 
        IF F10=5 THEN GROUP2="F10_5"; 
        IF M7=1 THEN GROUP3="M7_1"; 
        IF M7=2 THEN GROUP3="M7_2"; 
        IF M7=3 THEN GROUP3="M7_3"; 
        IF M7=4 THEN GROUP3="M7_4"; 
        IF M7=5 THEN GROUP3="M7_5"; 
        IF M8=1 THEN GROUP4="M8_1"; 
        IF M8=2 THEN GROUP4="M8_2"; 
        IF M8=3 THEN GROUP4="M8_3"; 
        IF M8=4 THEN GROUP4="M8_4"; 
        IF M8=5 THEN GROUP4="M8_5"; 
        Y=PB_C_1; TIME=1; OUTPUT; 
        Y=PB_C_3; TIME=3; OUTPUT; 
        Y=PB_C_6; TIME=6; OUTPUT; 
        Y=PB_C_12; TIME=12; OUTPUT; 
        Y=PB_C_18; TIME=18; OUTPUT; 
        Y=PB_C_24; TIME=24; OUTPUT; 
        Y=PB_C_30; TIME=30; OUTPUT; 
        Y=PB_C_36; TIME=36; OUTPUT; 
        Y=PB_C_42; TIME=42; OUTPUT; 
        Y=PB_C_48; TIME=48; OUTPUT; 
        Y=PB_C_60; TIME=60; OUTPUT; 
        DROP F9 F10 M7 M8 PB_C_1 PB_C_3 PB_C_6 PB_C_12 PB_C_18 PB_C_24 PB_C_30 
PB_C_36 PB_C_42 PB_C_48 PB_C_60; 
RUN; 
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PROC PRINT DATA=NEWDATAC2; 
RUN; 
 
/*F9 GROUP MEAN RESPONSE TIME PLOT*/ 
DATA NEWDATAC2G1; 
        SET NEWDATAC2(WHERE=(Y NE .)); 
RUN; 
 
DATA NEWDATAC2G1; 
        SET NEWDATAC2G1(WHERE=(GROUP1 NE "")); 
RUN; 
 
PROC SORT DATA=NEWDATAC2G1; 
        BY GROUP1 TIME; 
RUN; 
 
PROC MEANS DATA=NEWDATAC2G1; 
        VAR Y;  
        BY GROUP1 TIME; 
        OUTPUT OUT=NEWDATAC2G1_MEAN1 MEAN=MEANY; 
RUN; 
 
SYMBOL1 INTERPOL=JOIN VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2; 
SYMBOL2 INTERPOL=JOIN VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2; 
SYMBOL3 INTERPOL=JOIN VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2; 
SYMBOL4 INTERPOL=JOIN VALUE=HASHFILLED COLOR=VIP HEIGHT=2; 
SYMBOL5 INTERPOL=JOIN VALUE=STARFILLED COLOR=VIOY HEIGHT=2; 
 
PROC GPLOT DATA=NEWDATAC2G1_MEAN1; 
        AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)"); 
        AXIS2 LABEL=(ANGLE=90 "CHILD BLOOD LEAD LEVEL"); 
        PLOT MEANY*TIME=GROUP1/HAXIS=AXIS1 VAXIS=AXIS2; 
        TITLE "TIME PLOT 1 FOR CHILD BLOOD LEAD LEVEL (FEMALE)"; 
RUN;  
 
/*F10 GROUP MEAN RESPONSE TIME PLOT*/ 
DATA NEWDATAC2G2; 
        SET NEWDATAC2(WHERE=(Y NE .)); 
RUN; 
 
DATA NEWDATAC2G2; 
        SET NEWDATAC2G2(WHERE=(GROUP2 NE "")); 
RUN; 
 
PROC SORT DATA=NEWDATAC2G2; 
        BY GROUP2 TIME; 
RUN; 
 
PROC MEANS DATA=NEWDATAC2G2; 
        VAR Y;  
        BY GROUP2 TIME; 
        OUTPUT OUT=NEWDATAC2G2_MEAN1 MEAN=MEANY; 
RUN; 
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SYMBOL1 INTERPOL=JOIN VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2; 
SYMBOL2 INTERPOL=JOIN VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2; 
SYMBOL3 INTERPOL=JOIN VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2; 
SYMBOL4 INTERPOL=JOIN VALUE=HASHFILLED COLOR=VIP HEIGHT=2; 
SYMBOL5 INTERPOL=JOIN VALUE=STARFILLED COLOR=VIOY HEIGHT=2; 
 
PROC GPLOT DATA=NEWDATAC2G2_MEAN1; 
        AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)"); 
        AXIS2 LABEL=(ANGLE=90 "CHILD BLOOD LEAD LEVEL"); 
        PLOT MEANY*TIME=GROUP2/HAXIS=AXIS1 VAXIS=AXIS2; 
        TITLE "TIME PLOT 2 FOR CHILD BLOOD LEAD LEVEL (FEMALE)"; 
RUN;  
 
/*M7 GROUP MEAN RESPONSE TIME PLOT*/ 
DATA NEWDATAC2G3; 
        SET NEWDATAC2(WHERE=(Y NE .)); 
RUN; 
 
PROC PRINT DATA=NEWDATAC2G3; 
RUN; 
 
DATA NEWDATAC2G3; 
        SET NEWDATAC2G3(WHERE=(GROUP3 NE "")); 
RUN; 
 
PROC SORT DATA=NEWDATAC2G3; 
        BY GROUP3 TIME; 
RUN; 
 
PROC MEANS DATA=NEWDATAC2G3; 
        VAR Y;  
        BY GROUP3 TIME; 
        OUTPUT OUT=NEWDATAC2G3_MEAN1 MEAN=MEANY; 
RUN; 
 
SYMBOL1 INTERPOL=JOIN VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2; 
SYMBOL2 INTERPOL=JOIN VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2; 
SYMBOL3 INTERPOL=JOIN VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2; 
SYMBOL4 INTERPOL=JOIN VALUE=HASHFILLED COLOR=VIP HEIGHT=2; 
SYMBOL5 INTERPOL=JOIN VALUE=STARFILLED COLOR=VIOY HEIGHT=2; 
 
PROC GPLOT DATA=NEWDATAC2G3_MEAN1; 
        AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)"); 
        AXIS2 LABEL=(ANGLE=90 "CHILD BLOOD LEAD LEVEL"); 
        PLOT MEANY*TIME=GROUP3/HAXIS=AXIS1 VAXIS=AXIS2; 
        TITLE "TIME PLOT 3 FOR CHILD BLOOD LEAD LEVEL (MALE)"; 
RUN;  
 
/*M8 GROUP MEAN RESPONSE TIME PLOT*/ 
DATA NEWDATAC2G4; 
        SET NEWDATAC2(WHERE=(Y NE .)); 
RUN; 
 
PROC PRINT DATA=NEWDATAC2G4; 
RUN; 
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DATA NEWDATAC2G4; 
        SET NEWDATAC2G4(WHERE=(GROUP4 NE "")); 
RUN; 
 
PROC SORT DATA=NEWDATAC2G4; 
        BY GROUP4 TIME; 
RUN; 
 
PROC MEANS DATA=NEWDATAC2G4; 
        VAR Y;  
        BY GROUP4 TIME; 
        OUTPUT OUT=NEWDATAC2G4_MEAN1 MEAN=MEANY; 
RUN; 
 
SYMBOL1 INTERPOL=JOIN VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2; 
SYMBOL2 INTERPOL=JOIN VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2; 
SYMBOL3 INTERPOL=JOIN VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2; 
SYMBOL4 INTERPOL=JOIN VALUE=HASHFILLED COLOR=VIP HEIGHT=2; 
SYMBOL5 INTERPOL=JOIN VALUE=STARFILLED COLOR=VIOY HEIGHT=2; 
 
PROC GPLOT DATA=NEWDATAC2G4_MEAN1; 
        AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)"); 
        AXIS2 LABEL=(ANGLE=90 "CHILD BLOOD LEAD LEVEL"); 
        PLOT MEANY*TIME=GROUP4/HAXIS=AXIS1 VAXIS=AXIS2; 
        TITLE "TIME PLOT 4 FOR CHILD BLOOD LEAD LEVEL (MALE)"; 
RUN;  
 
 
/*MOTHER BLOOD LEAD*/ 
DATA NEWDATA1_1; 
        SET DATA; 
        KEEP FAKEID SEX_CH F9 F10 M7 M8 PB_M_11 PB_M_12 PB_M_13 PB_M_20 PB_M_21 
PB_M_23 PB_M_24 PB_M_27 PB_M_212; 
RUN; 
 
DATA NEWDATAM2; 
        SET NEWDATA1_1; 
        IF F9=1 THEN GROUP1="F9_1"; 
        IF F9=2 THEN GROUP1="F9_2"; 
        IF F9=3 THEN GROUP1="F9_3"; 
        IF F9=4 THEN GROUP1="F9_4"; 
        IF F9=5 THEN GROUP1="F9_5"; 
        IF F10=1 THEN GROUP2="F10_1"; 
        IF F10=2 THEN GROUP2="F10_2"; 
        IF F10=3 THEN GROUP2="F10_3"; 
        IF F10=4 THEN GROUP2="F10_4"; 
        IF F10=5 THEN GROUP2="F10_5"; 
        IF M7=1 THEN GROUP3="M7_1"; 
        IF M7=2 THEN GROUP3="M7_2"; 
        IF M7=3 THEN GROUP3="M7_3"; 
        IF M7=4 THEN GROUP3="M7_4"; 
        IF M7=5 THEN GROUP3="M7_5"; 
        IF M8=1 THEN GROUP4="M8_1"; 
        IF M8=2 THEN GROUP4="M8_2"; 
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        IF M8=3 THEN GROUP4="M8_3"; 
        IF M8=4 THEN GROUP4="M8_4"; 
        IF M8=5 THEN GROUP4="M8_5"; 
        Y=PB_M_11; TIME=-3; OUTPUT; 
        Y=PB_M_12; TIME=-2; OUTPUT; 
        Y=PB_M_13; TIME=-1; OUTPUT; 
        Y=PB_M_20; TIME=0; OUTPUT; 
        Y=PB_M_21; TIME=1; OUTPUT; 
        Y=PB_M_23; TIME=3; OUTPUT; 
        Y=PB_M_24; TIME=4; OUTPUT; 
        Y=PB_M_27; TIME=7; OUTPUT; 
        Y=PB_M_212; TIME=12; OUTPUT; 
        DROP F9 F10 M7 M8 PB_M_11 PB_M_12 PB_M_13 PB_M_20 PB_M_21 PB_M_23 PB_M_24 
PB_M_27 PB_M_212; 
RUN; 
 
PROC PRINT DATA=NEWDATAM2; 
RUN; 
 
/*F9 GROUP MEAN RESPONSE TIME PLOT*/ 
DATA NEWDATAM2G1; 
        SET NEWDATAM2(WHERE=(Y NE .)); 
RUN; 
 
DATA NEWDATAM2G1; 
        SET NEWDATAM2G1(WHERE=(GROUP1 NE "")); 
RUN; 
 
PROC SORT DATA=NEWDATAM2G1; 
        BY GROUP1 TIME; 
RUN; 
 
PROC MEANS DATA=NEWDATAM2G1; 
        VAR Y;  
        BY GROUP1 TIME; 
        OUTPUT OUT=NEWDATAM2G1_MEAN1 MEAN=MEANY; 
RUN; 
 
SYMBOL1 INTERPOL=JOIN VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2; 
SYMBOL2 INTERPOL=JOIN VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2; 
SYMBOL3 INTERPOL=JOIN VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2; 
SYMBOL4 INTERPOL=JOIN VALUE=HASHFILLED COLOR=VIP HEIGHT=2; 
SYMBOL5 INTERPOL=JOIN VALUE=STARFILLED COLOR=VIOY HEIGHT=2; 
 
PROC GPLOT DATA=NEWDATAM2G1_MEAN1; 
        AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)"); 
        AXIS2 LABEL=(ANGLE=90 "MOTHER BLOOD LEAD LEVEL"); 
        PLOT MEANY*TIME=GROUP1/HAXIS=AXIS1 VAXIS=AXIS2; 
        TITLE "TIME PLOT 1 FOR MOTHER BLOOD LEAD LEVEL (FEMALE)"; 
RUN;  
 
/*F10 GROUP MEAN RESPONSE TIME PLOT*/ 
DATA NEWDATAM2G2; 
        SET NEWDATAM2(WHERE=(Y NE .)); 
RUN; 
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DATA NEWDATAM2G2; 
        SET NEWDATAM2G2(WHERE=(GROUP2 NE "")); 
RUN; 
 
PROC SORT DATA=NEWDATAM2G2; 
        BY GROUP2 TIME; 
RUN; 
 
PROC MEANS DATA=NEWDATAM2G2; 
        VAR Y;  
        BY GROUP2 TIME; 
        OUTPUT OUT=NEWDATAM2G2_MEAN1 MEAN=MEANY; 
RUN; 
 
SYMBOL1 INTERPOL=JOIN VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2; 
SYMBOL2 INTERPOL=JOIN VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2; 
SYMBOL3 INTERPOL=JOIN VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2; 
SYMBOL4 INTERPOL=JOIN VALUE=HASHFILLED COLOR=VIP HEIGHT=2; 
SYMBOL5 INTERPOL=JOIN VALUE=STARFILLED COLOR=VIOY HEIGHT=2; 
 
PROC GPLOT DATA=NEWDATAM2G2_MEAN1; 
        AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)"); 
        AXIS2 LABEL=(ANGLE=90 "MONTH BLOOD LEAD LEVEL"); 
        PLOT MEANY*TIME=GROUP2/HAXIS=AXIS1 VAXIS=AXIS2; 
        TITLE "TIME PLOT 2 FOR MOTHER BLOOD LEAD LEVEL (FEMALE)"; 
RUN;  
 
/*M7 GROUP MEAN RESPONSE TIME PLOT*/ 
DATA NEWDATAM2G3; 
        SET NEWDATAM2(WHERE=(Y NE .)); 
RUN; 
 
PROC PRINT DATA=NEWDATAM2G3; 
RUN; 
 
DATA NEWDATAM2G3; 
        SET NEWDATAM2G3(WHERE=(GROUP3 NE "")); 
RUN; 
 
PROC SORT DATA=NEWDATAM2G3; 
        BY GROUP3 TIME; 
RUN; 
 
PROC MEANS DATA=NEWDATAM2G3; 
        VAR Y;  
        BY GROUP3 TIME; 
        OUTPUT OUT=NEWDATAM2G3_MEAN1 MEAN=MEANY; 
RUN; 
 
SYMBOL1 INTERPOL=JOIN VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2; 
SYMBOL2 INTERPOL=JOIN VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2; 
SYMBOL3 INTERPOL=JOIN VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2; 
SYMBOL4 INTERPOL=JOIN VALUE=HASHFILLED COLOR=VIP HEIGHT=2; 
SYMBOL5 INTERPOL=JOIN VALUE=STARFILLED COLOR=VIOY HEIGHT=2; 
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PROC GPLOT DATA=NEWDATAM2G3_MEAN1; 
        AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)"); 
        AXIS2 LABEL=(ANGLE=90 "MOTHER BLOOD LEAD LEVEL"); 
        PLOT MEANY*TIME=GROUP3/HAXIS=AXIS1 VAXIS=AXIS2; 
        TITLE "TIME PLOT 3 FOR MOTHER BLOOD LEAD LEVEL (MALE)"; 
RUN;  
 
/*M8 GROUP MEAN RESPONSE TIME PLOT*/ 
DATA NEWDATAM2G4; 
        SET NEWDATAM2(WHERE=(Y NE .)); 
RUN; 
 
PROC PRINT DATA=NEWDATAM2G4; 
RUN; 
 
DATA NEWDATAM2G4; 
        SET NEWDATAM2G4(WHERE=(GROUP4 NE "")); 
RUN; 
 
PROC SORT DATA=NEWDATAM2G4; 
        BY GROUP4 TIME; 
RUN; 
 
PROC MEANS DATA=NEWDATAM2G4; 
        VAR Y;  
        BY GROUP4 TIME; 
        OUTPUT OUT=NEWDATAM2G4_MEAN1 MEAN=MEANY; 
RUN; 
 
SYMBOL1 INTERPOL=JOIN VALUE=SQUAREFILLED COLOR=VIBG HEIGHT=2; 
SYMBOL2 INTERPOL=JOIN VALUE=TRIANGLEFILLED COLOR=DEPK HEIGHT=2; 
SYMBOL3 INTERPOL=JOIN VALUE=DIAMONDFILLED COLOR=MOB HEIGHT=2; 
SYMBOL4 INTERPOL=JOIN VALUE=HASHFILLED COLOR=VIP HEIGHT=2; 
SYMBOL5 INTERPOL=JOIN VALUE=STARFILLED COLOR=VIOY HEIGHT=2; 
 
PROC GPLOT DATA=NEWDATAM2G4_MEAN1; 
        AXIS1 LABEL=(ANGLE=0 "TIME (MONTHS)"); 
        AXIS2 LABEL=(ANGLE=90 "MOTHER BLOOD LEAD LEVEL"); 
        PLOT MEANY*TIME=GROUP4/HAXIS=AXIS1 VAXIS=AXIS2; 
        TITLE "TIME PLOT 4 FOR MOTHER BLOOD LEAD LEVEL (MALE)"; 
RUN;  
 
 
/************************************************************ PART III BOXPLOT 
*************************************************/ 
/* BOXPLOT FOR CHILD BLOOD BY TIME*/ 
SYMBOL VALUE=DOT HEIGHT=.4 INTERPOL=BOXTF WIDTH=3 BWIDTH=5 COLOR=BLACK CV=TAN; 
 
AXIS1 ORDER=(0 TO 45 BY 10) LABEL=(HEIGHT=1.25 ANGLE=90 'CHILD BLOOD LEAD') 
MINOR=(NUMBER=1); 
 
AXIS2  LABEL=(HEIGHT=1.25 'TIME (MONTHS)') OFFSET=(5,5); 
 
PROC GPLOT DATA=NEWDATAC2 UNIFORM; 
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        PLOT Y*TIME /HAXIS=AXIS2 VAXIS=AXIS1 HMINOR=0 SKIPMISS; 
        TITLE "BOXPLOT FOR CHILD BLOOD LEAD OVER TIME"; 
RUN; 
 
/* BOXPLOT FOR MOTHER BLOOD BY TIME*/ 
SYMBOL VALUE=DOT HEIGHT=.4 INTERPOL=BOXTF WIDTH=3 BWIDTH=5 COLOR=BLACK CV=TAN; 
 
AXIS1 ORDER=(0 TO 45 BY 10) LABEL=(HEIGHT=1.25 ANGLE=90 'MOTHER BLOOD LEAD') 
MINOR=(NUMBER=1); 
 
AXIS2  LABEL=(HEIGHT=1.25 'TIME (MONTHS)') OFFSET=(5,5); 
 
PROC GPLOT DATA=NEWDATAM2 UNIFORM; 
        PLOT Y*TIME /HAXIS=AXIS2 VAXIS=AXIS1 HMINOR=0 SKIPMISS; 
        TITLE "BOXPLOT FOR MOTHER BLOOD LEAD OVER TIME"; 
RUN; 
 
/************************************************************ PART IV 
CHARACTERISTICS *************************************************/ 
/*TABLE FOR F9*/ 
/*F91*/ 
DATA F91; 
        SET DATA(WHERE=(F9 EQ 1)); 
RUN; 
 
PROC PRINT DATA=F91; 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=F91; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F91; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F91; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*F92*/ 
DATA F92; 
        SET DATA(WHERE=(F9 EQ 2)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=F92; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F92; 
        TABLES SMHX SMPREG; 
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RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F92; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*F93*/ 
DATA F93; 
        SET DATA(WHERE=(F9 EQ 3)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=F93; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F93; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F93; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*F94*/ 
DATA F94; 
        SET DATA(WHERE=(F9 EQ 4)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=F94; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F94; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F94; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*F95*/ 
DATA F95; 
        SET DATA(WHERE=(F9 EQ 5)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=F95; 
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        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F95; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F95; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN;  
 
 
/*TABLE FOR F10*/ 
/*F101*/ 
DATA F101; 
        SET DATA(WHERE=(F10 EQ 1)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=F101; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F101; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F101; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*F102*/ 
DATA F102; 
        SET DATA(WHERE=(F10 EQ 2)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=F102; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F102; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F102; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*F103*/ 
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DATA F103; 
        SET DATA(WHERE=(F10 EQ 3)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=F103; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F103; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F103; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*F104*/ 
DATA F104; 
        SET DATA(WHERE=(F10 EQ 4)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATA=F104; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F104; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F104; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*F105*/ 
DATA F105; 
        SET DATA(WHERE=(F10 EQ 5)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATA=F105; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=F105; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=F105; 
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        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*TABLE FOR M7*/ 
/*FM71*/ 
DATA M71; 
        SET DATA(WHERE=(M7 EQ 1)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=M71; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=M71; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M71; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*M72*/ 
DATA M72; 
        SET DATA(WHERE=(M7 EQ 2)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=M72; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=M72; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M72; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*M73*/ 
DATA M73; 
        SET DATA(WHERE=(M7 EQ 3)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=M73; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
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PROC FREQ DATA=M73; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M73; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*M74*/ 
DATA M74; 
        SET DATA(WHERE=(M7 EQ 4)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATA=M74; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=M74; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M74; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*M75*/ 
DATA M75; 
        SET DATA(WHERE=(M7 EQ 5)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATA=M75; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=M75; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M75; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
 
/*TABLE FOR M8*/ 
/*FM81*/ 
DATA M81; 
        SET DATA(WHERE=(M8 EQ 1)); 
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RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=M81; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=M81; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M81; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*M82*/ 
DATA M82; 
        SET DATA(WHERE=(M8 EQ 2)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=M82; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=M82; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M82; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*M83*/ 
DATA M83; 
        SET DATA(WHERE=(M8 EQ 3)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATADATA=M83; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=M83; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M83; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
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/*M84*/ 
DATA M84; 
        SET DATA(WHERE=(M8 EQ 4)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATA=M84; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=M84; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M84; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
/*M85*/ 
DATA M85; 
        SET DATA(WHERE=(M8 EQ 5)); 
RUN; 
 
/*MATERNAL*/ 
PROC UNIVARIATE DATA=M85; 
        VAR AGE_M PREPREGNANCYBMI BF_TOTAL_1STRECALL; 
RUN; 
 
PROC FREQ DATA=M85; 
        TABLES SMHX SMPREG; 
RUN; 
 
/*CHILD*/ 
PROC UNIVARIATE DATA=M85; 
        VAR DELIVERY_WEIGHT DELIVERY_HEIGHT DELIVERY_HEADCIRC PR_DIAS PR_SIS X_CBMI; 
RUN; 
 
 
